Foray Bioscience
PrivateLast Round
Seed
Jun 25, 2024
Total Funding Raised
$3.88M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Foray Bioscience is a biotechnology company that develops plant cell culture and biomanufacturing technologies to produce harvest-free plant-based materials, molecules, and seeds.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Sustainable Materials, Vertical SaaS, Clean Manufacturing
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Foray Bioscience Comparables
Compare Foray Bioscience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ayana Bio | 66% | |
| Benchling | 62% | |
| DFB Pharmaceuticals | 60% |
Foray Bioscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jun 25, 2024 | ||||
| Pre Seed | Jul 1, 2023 |
Foray Bioscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Engine | Seed |
| Engine Ventures | Seed |
| Susquehanna Sustainable Investments | Seed |
| Understorey Ventures | Seed |
| Regenerative Ventures Holdings | Seed |
| U.S. Department of Agriculture | Pre Seed |
| Superorganism | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 419% MoM, reaching 4.4K.
- Jul 17, 2026
Grew 18% QoQ, from 17 to 20 employees.
Recent news
Latest coverage and updates
- is_developingJun 29, 2026
Foraybio is developing fabricated seeds on Jun 29th '26.
Foray Bioscience Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Foray Bioscience's valuation, stock price, and market status.
Is Foray a public or private company?
Foray is a private company.
What is the current stock price of Foray?
Foray is a private company with no public stock price. No recent secondary market data is available.
How much is Foray worth (valuation)?
Valuation information for Foray is not publicly available.
Can I buy Foray stock?
Foray shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Foray's last funding round?
Foray's most recent funding round was Seed on June 25, 2024.
Who are the main investors in Foray?
Key investors in Foray include Regenerative Ventures Holdings.
Will Foray IPO soon?
No public IPO plans have been announced for Foray.
How can I track Foray secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Foray's secondary market activity and sign up for updates.